ENZO BIOCHEM INC Quarterly Intangible Assets, Net (Excluding Goodwill) in USD from Q2 2011 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Summary
Enzo Biochem Inc quarterly Intangible Assets, Net (Excluding Goodwill) history and growth rate from Q2 2011 to Q1 2022.
  • Enzo Biochem Inc Intangible Assets, Net (Excluding Goodwill) for the quarter ending April 30, 2022 was $29K, a 90.8% decline year-over-year.
Intangible Assets, Net (Excluding Goodwill), Quarterly (USD)
Intangible Assets, Net (Excluding Goodwill), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $29K -$286K -90.8% Apr 30, 2022 10-Q 2022-06-09
Q4 2021 $100K -$293K -74.6% Jan 31, 2022 10-Q 2022-03-14
Q3 2021 $171K -$289K -62.8% Oct 31, 2021 10-Q 2021-12-15
Q2 2021 $244K -$294K -54.6% Jul 31, 2021 10-K 2022-10-14
Q1 2021 $315K -$273K -46.4% Apr 30, 2021 10-Q 2021-06-11
Q4 2020 $393K -$359K -47.7% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 $460K -$432K -48.4% Oct 31, 2020 10-Q 2020-12-11
Q2 2020 $538K -$494K -47.9% Jul 31, 2020 10-K 2021-10-12
Q1 2020 $588K -$540K -47.9% Apr 30, 2020 10-Q 2020-06-09
Q4 2019 $752K -$636K -45.8% Jan 31, 2020 10-Q 2020-03-06
Q3 2019 $892K -$733K -45.1% Oct 31, 2019 10-Q 2019-12-10
Q2 2019 $1.03M -$854K -45.3% Jul 31, 2019 10-K 2020-10-19
Q1 2019 $1.13M -$1.02M -47.5% Apr 30, 2019 10-Q 2019-06-10
Q4 2018 $1.39M -$1.06M -43.3% Jan 31, 2019 10-Q 2019-03-11
Q3 2018 $1.63M -$1.02M -38.6% Oct 31, 2018 10-Q 2018-12-10
Q2 2018 $1.89M -$1.01M -34.9% Jul 31, 2018 10-K 2019-10-15
Q1 2018 $2.15M -$1.1M -33.8% Apr 30, 2018 10-Q 2018-06-11
Q4 2017 $2.45M -$1.11M -31.2% Jan 31, 2018 10-Q 2018-03-12
Q3 2017 $2.65M -$1.32M -33.3% Oct 31, 2017 10-Q 2017-12-07
Q2 2017 $2.9M -$1.53M -34.5% Jul 31, 2017 10-K 2018-10-15
Q1 2017 $3.24M -$1.64M -33.6% Apr 30, 2017 10-Q 2017-06-08
Q4 2016 $3.56M -$1.66M -31.8% Jan 31, 2017 10-Q 2017-03-13
Q3 2016 $3.97M -$1.74M -30.4% Oct 31, 2016 10-Q 2016-12-08
Q2 2016 $4.42M -$1.73M -28.2% Jul 31, 2016 10-K 2017-09-27
Q1 2016 $4.88M -$1.77M -26.6% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 $5.22M -$1.9M -26.7% Jan 31, 2016 10-Q 2016-03-09
Q3 2015 $5.71M -$1.85M -24.5% Oct 31, 2015 10-Q 2015-12-08
Q2 2015 $6.16M -$1.95M -24.1% Jul 31, 2015 10-K 2016-10-13
Q1 2015 $6.66M -$2.06M -23.6% Apr 30, 2015 10-Q 2015-06-09
Q4 2014 $7.12M -$1.99M -21.8% Jan 31, 2015 10-Q 2015-03-12
Q3 2014 $7.56M -$2.01M -21% Oct 31, 2014 10-Q 2014-12-09
Q2 2014 $8.11M -$1.84M -18.5% Jul 31, 2014 10-K 2015-10-13
Q1 2014 $8.71M -$1.7M -16.3% Apr 30, 2014 10-Q 2014-06-09
Q4 2013 $9.11M -$1.86M -17% Jan 31, 2014 10-Q 2014-03-11
Q3 2013 $9.56M -$1.86M -16.3% Oct 31, 2013 10-Q 2013-12-10
Q2 2013 $9.94M -$1.84M -15.6% Jul 31, 2013 10-K 2014-10-09
Q1 2013 $10.4M -$7.93M -43.2% Apr 30, 2013 10-Q 2013-06-10
Q4 2012 $11M -$7.66M -41.1% Jan 31, 2013 10-Q 2013-03-12
Q3 2012 $11.4M -$7.89M -40.9% Oct 31, 2012 10-Q 2012-12-10
Q2 2012 $11.8M -$8.21M -41.1% Jul 31, 2012 10-K 2013-10-15
Q1 2012 $18.3M Apr 30, 2012 10-Q 2012-06-11
Q4 2011 $18.6M Jan 31, 2012 10-Q 2012-03-12
Q3 2011 $19.3M Oct 31, 2011 10-Q 2011-12-12
Q2 2011 $20M Jul 31, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.